LGN

Legence Corp. Class A Common stock

$63.93

+6.89%
Jul 31, 2026
Bobby Quantitative Model
Legence Corp. is a provider of engineering, installation, and maintenance services for critical building systems, specializing in HVAC, process piping, and other mechanical, electrical, and plumbing (MEP) systems for sectors like technology, life sciences, healthcare, and education. As a niche player in the Engineering & Construction industry, Legence differentiates itself through its focus on technically demanding buildings and its dual-segment model of Installation and Maintenance, which generates the majority of revenue, and Engineering and Consulting. The current investor narrative centers on the company's rapid growth since its September 2025 IPO, with the stock surging 80% initially, driven by strong operational momentum and a $24 million institutional investment, but recent quarters have shown volatility and a sharp pullback from highs, raising questions about sustainability and execution. The market is closely watching Legence's ability to maintain its growth trajectory while managing profitability and debt levels in a capital-intensive industry.

People also watch

Quanta Services

Quanta Services

PWR

Analysis
Comfort Systems USA

Comfort Systems USA

FIX

Analysis
EMCOR

EMCOR

EME

Analysis
MasTec

MasTec

MTZ

Analysis
Sterling Infrastructure, Inc. Common Stock

Sterling Infrastructure, Inc. Common Stock

STRL

Analysis

BobbyInvestment Opinion: Should I buy LGN Today?

Based on the analysis, LGN is rated a Buy. The consensus Strong Buy rating from 17 analysts, with an average target price of $105.71 (65.4% upside), supports this view. The thesis is that Legence's rapid revenue growth, recent profitability, and strategic positioning in critical infrastructure will drive earnings expansion, justifying the current valuation.

Sign up to view all

LGN 12-Month Price Forecast

The AI assessment leans bullish due to the company's exceptional growth and analyst support, but confidence is medium given the high leverage and margin volatility. The stock's recent pullback offers a favorable entry point, but sustained profitability and margin improvement are critical to validate the thesis. If Q2 2026 earnings show continued growth and margin stabilization, the stance would upgrade to high confidence; conversely, any signs of deceleration or margin erosion would prompt a downgrade to neutral.

Historical Price
Current Price $63.93
Average Target $92.50
High Target $125.00
Low Target $50.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Legence Corp. Class A Common stock's 12-month outlook, with a consensus price target around $105.71 and implied upside of +65.3% versus the current price.

Average Target

$105.71

0 analysts

Implied Upside

+65.3%

vs. current price

Analyst Count

covering this stock

Price Range

$80 - $125

Analyst target range

Legence is covered by 17 analysts, with a consensus recommendation of 'Strong Buy' and a mean recommendation score of 1.24 (where 1 is Strong Buy and 5 is Sell). The average target price is $105.71, implying an upside of approximately 65.4% from the current price of $63.93. The distribution is heavily bullish, with no Sell ratings and only a few Hold/Equal Weight ratings, as seen in the institutional ratings data where most actions are Buy or Outperform. The target price range is from $80.00 (low) to $125.00 (high), with the high target suggesting that analysts expect the company to achieve strong revenue growth and margin expansion, possibly driven by increased demand for critical infrastructure and energy efficiency projects. The low target of $80.00 still implies a 25.1% upside, indicating that even the most bearish analyst sees value. The wide spread between low and high targets (45% difference) reflects high uncertainty about the company's execution and market conditions. Recent ratings actions have been mostly reaffirmations of Buy or Outperform, with no downgrades, suggesting that analysts remain confident despite the recent stock price decline. However, the stock's high volatility and recent drawdown of -48.1% from its high highlight the risks associated with this relatively new and leveraged company.

Drowning in data?

Find the real signal!

Bulls vs Bears: LGN Investment Factors

Legence presents a compelling growth story with explosive revenue growth, strong analyst support, and a recent profitability turnaround, but it is tempered by high leverage, margin compression, and significant volatility. The bull case is currently stronger, given the 65.4% upside to analyst targets and the company's strategic position in critical infrastructure, but the bear case highlights execution risks and financial fragility. The most critical tension is whether the company can sustain its growth while improving margins and managing debt; if it fails, the stock could see further downside, but if it succeeds, the upside is substantial.

Bullish

  • Explosive Revenue Growth: Q1 2026 revenue surged 105.14% YoY to $1.038B, driven by strong demand in critical infrastructure. This growth rate far exceeds typical industry peers, indicating robust market positioning and successful execution of its growth strategy.
  • Strong Analyst Conviction: 17 analysts rate LGN a Strong Buy with a mean score of 1.24, and the average target price of $105.71 implies 65.4% upside from the current price of $63.93. No sell ratings and a low target of $80 still offer 25.1% upside, reflecting broad confidence.
  • Positive Free Cash Flow: Q1 2026 free cash flow was $102.29M, with TTM FCF of $297.13M. This provides a cushion for debt servicing and investments, reducing liquidity risk despite high leverage.
  • Recent Profitability Turnaround: LGN turned profitable in Q1 2026 with net income of $16.09M, a significant improvement from the -$32.72M loss in Q4 2025. This inflection point, if sustained, could drive earnings revisions and multiple expansion.

Bearish

  • High Leverage and Interest Burden: Debt-to-equity ratio is 2.43, and Q1 2026 interest expense was $17M, which consumed a significant portion of operating income. This leverage amplifies financial risk, especially if revenue growth slows or margins compress further.
  • Margin Compression: Gross margin fell to 14.39% in Q1 2026 from 19.99% in Q4 2025 and 21.41% in Q2 2025. Operating margin is only 3.20%, reflecting intense competition and cost pressures, which could limit profitability gains.
  • Decelerating Sequential Growth: Revenue grew from $708M in Q3 2025 to $737.6M in Q4 2025, but Q1 2026 revenue of $1.038B includes a massive YoY jump, yet sequential growth is not provided. The initial post-IPO surge may be fading, as evidenced by the stock's -48.1% drawdown from its high.
  • Negative Trailing EPS and ROE: Trailing EPS is -$0.0234, and ROE is -15.24%, indicating that the company has not yet demonstrated consistent profitability. This makes the stock unsuitable for income-focused investors and raises questions about long-term value creation.

LGN Technical Analysis

Legence's stock has exhibited a dramatic uptrend since its IPO, with the price rising from a 52-week low of $26.96 to a high of $107.238, and currently trading at $63.93, which is approximately 59.6% of its 52-week range. The 1-year price change is not directly available, but the 6-month change of +36.28% and YTD change of +43.08% indicate a strong longer-term uptrend, though the stock has recently corrected significantly from its peak. This positioning near the middle of the range suggests a consolidation phase after a parabolic rise, with the potential for either a continuation or a deeper correction depending on market sentiment and fundamentals.

Beta

Max Drawdown

-48.1%

Largest decline past year

52-Week Range

$27-$107

Price range past year

Annual Return

Cumulative gain past year

PeriodLGN ReturnS&P 500
1m-20.1%+0.3%
3m-29.0%+4.0%
6m+36.3%+8.3%
1y+20.2%
ytd+43.1%+9.6%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

LGN Fundamental Analysis

Legence's revenue has grown robustly, with the most recent quarter (Q1 2026) reporting revenue of $1.0379 billion, a 105.14% YoY increase from $505.95 million in Q1 2025. This growth is driven by both segments, with Installation and Maintenance contributing $872.09 million and Engineering and Consulting $165.80 million, though the latter is smaller. However, the growth rate is decelerating sequentially, as Q4 2025 revenue was $737.64 million, and Q3 2025 was $708.01 million, indicating a slowdown from the initial post-IPO surge. The company turned profitable in Q1 2026 with net income of $16.09 million, a significant improvement from the net losses in the prior four quarters, including a -$32.72 million loss in Q4 2025. Gross margin in Q1 2026 was 14.39%, down from 19.99% in Q4 2025 and 21.41% in Q2 2025, suggesting margin compression due to project mix and costs. Operating margin was 3.20% in Q1 2026, up from 1.07% in Q4 2025, but still low, reflecting the competitive nature of the engineering and construction industry. The company's balance sheet shows a debt-to-equity ratio of 2.43, indicating high leverage, and a current ratio of 1.57, which is adequate for liquidity. Free cash flow for Q1 2026 was $102.29 million, a strong positive, and TTM free cash flow is $297.13 million, providing some cushion, but the high debt levels and interest expenses of $17 million in Q1 2026 remain a concern. ROE is negative at -15.24%, reflecting the recent losses, though the latest quarter's profitability is a positive sign.

Quarterly Revenue

$1.0B

2026-03

Revenue YoY Growth

+105.1%

YoY Comparison

Gross Margin

14.4%

Latest Quarter

Free Cash Flow

$297126000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Engineering And Consulting
Installation And Maintenance

Open an Account, get $2 TSLA now!

Valuation Analysis: Is LGN Overvalued?

Given that Legence has negative trailing EPS (-$0.0234), the price-to-earnings ratio is not meaningful, so I selected the price-to-sales (PS) ratio as the primary valuation metric. The trailing PS ratio is 1.00, based on TTM revenue of approximately $3.05 billion (sum of last four quarters), and the forward PS ratio is not directly provided but can be estimated using estimated revenue of $6.63 billion, implying a forward PS of about 0.69, indicating the market expects significant revenue growth. The PEG ratio of 0.037 is extremely low, suggesting that the stock is undervalued relative to its growth potential, but this is based on forward EPS estimates that may be optimistic. Compared to the industry average PS ratio (not provided, but typically around 1.5-2.0 for engineering and construction), Legence trades at a discount, which could be justified by its lower margins and high debt. Historically, the PS ratio has ranged from 2.55 to 3.65 over the past year, so the current PS of 1.00 is near the bottom of its historical range, indicating a potential value opportunity or a reflection of deteriorating fundamentals. The EV-to-Sales ratio of 1.94 is higher than the PS ratio due to debt, and EV-to-EBITDA of 33.04 is elevated, suggesting that the market is pricing in high growth expectations.

PE

-42.6x

Latest Quarter

vs. Historical

N/A

5-Year PE Range 17x~59x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

33.0x

Enterprise Value Multiple

Investment Risk Disclosure

Financially, Legence carries a high debt-to-equity ratio of 2.43, with interest expenses of $17M in Q1 2026, which consumed over half of its operating income of $33.2M. The company's gross margin has compressed from 21.41% in Q2 2025 to 14.39% in Q1 2026, indicating cost pressures that could erode profitability. While free cash flow turned positive at $102.29M in Q1 2026, the negative trailing EPS of -$0.0234 and ROE of -15.24% highlight that the company has not yet proven consistent earnings power. Revenue concentration in the Installation and Maintenance segment (84% of Q1 revenue) exposes it to project delays or cancellations in cyclical end-markets like technology and life sciences.

FAQ

The key risks include: 1) Financial risk from high leverage (debt-to-equity of 2.43) and interest expenses that consume a large portion of operating income. 2) Operational risk from margin compression, with gross margin falling to 14.39% in Q1 2026 from 21.41% in Q2 2025. 3) Market risk from high volatility, as evidenced by the -48.1% drawdown from its high, and underperformance relative to the S&P 500. 4) Company-specific risk of revenue concentration in cyclical sectors like technology and life sciences, which could be hit by economic downturns.

The 12-month forecast is bullish, with a base case probability of 50% targeting $80-$105, a bull case probability of 30% targeting $105-$125, and a bear case probability of 20% targeting $50-$80. The most likely scenario is the base case, where the stock reaches the analyst average target of $105.71, driven by continued growth and stable margins. The key assumption is that revenue growth remains strong and the company achieves profitability on a sustained basis.

Based on trailing metrics, LGN appears undervalued with a PS ratio of 1.00, which is near the low end of its historical range of 2.55-3.65. The forward P/E of 36.02x is reasonable given the expected EPS growth, and the PEG ratio of 0.037 suggests significant undervaluation relative to growth. However, the high EV-to-EBITDA of 33.04 indicates that the market is pricing in high expectations, so the stock is not cheap on an absolute basis. Overall, the valuation is attractive if the company meets its growth targets, but it could be considered overvalued if growth disappoints.

LGN is a good buy for growth-oriented investors who can tolerate high volatility and have a long-term horizon. The stock offers a 65.4% upside to the average analyst target of $105.71, and the recent pullback to $63.93 provides an attractive entry point. However, the high debt-to-equity ratio of 2.43 and margin compression are significant risks. If you believe in the company's ability to sustain growth and improve margins, it is a compelling buy; otherwise, it may be better to wait for more evidence of stability.

LGN is more suitable for long-term investment (3-5 years) due to its high growth potential and the early stage of its public life. The stock is highly volatile, with a beta likely above 1, and has experienced a -48.1% drawdown, making it risky for short-term trading. The company's focus on critical infrastructure and energy efficiency provides secular tailwinds, but the high debt and margin pressures require time to resolve. A minimum holding period of 3 years is recommended to allow the growth story to play out and for the balance sheet to strengthen.